Tranexamic Acid Injection, Solution
Product Images NDC 51662-1532

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 51662-1532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Case Labeling (51662 1532 3 Case Labeling)

TRANEXAMIC ACID INJECTION is a medication that is to be used intravenously only. Each 10ml vial contains USP, 1,000mg of tranexamic acid. A box of 10 vials is available for use. The usual dosage required can be referred in the accompanying USP prescribing information. Store this medication at controlled room temperature (20° to 25°C) and discard any unused portion. The manufacturer of this injection is HF Acquistion Co., LLC located in Mukilteo, WA 98275. The medication has been assigned the Original NF6 NDC number 55150-188-10 and is only available with a prescription.*

FDA Label Image

Description (Description)

FDA Label Image

Dosage (Dosage)

The table shows the recommended Tranexamic Acid Injection Intravenous Dosage for patients with varying degrees of renal impairment based on their serum creatinine levels. Dosages range from 10 mg/kg twice daily for patients with serum creatinine levels of 2.83 (120 to 250 micromol/L) to 5 mg/kg every 24 hours for patients with serum creatinine levels above 5.66 (>500 micromol/L).*

FDA Label Image

Pouch Labeling (Pouch)

TRANEXAMIC ACID INJECTION, USP is a medication that comes in a 10mL vial containing 1000mg/10mL or 100mg/mL. It is intended for intravenous use only and should be stored at 20-25°C. The appropriate dosage should be determined based on the accompanying fibrin formation data. Any medication that has not been used should be discarded. This specific product was manufactured by HF Acquistion in Mukilteo, Washington and is only available with a prescription.*

FDA Label Image

Seerialized Labeling (Serialized Labeling)

This is a product identifier for an item called "12345" that requires the user to refer to the manufacturer's package insert for further information. It was distributed by HF Acquisition Co., LLC in Mukilteo, WA. The other numbers are likely internal codes that do not provide any useful information.*

FDA Label Image

Serialized Vial Labeling (Serialized Vial Labeling)

FDA Label Image

Vial Labeling (Vial Label)

AUROMEDICS is a pharmaceutical company that produces Tranexamic Acid Injection, which is only for intravenous use, in 1,000 mg per 10 mL (100 mg / mL), stored at a temperature of 20°-25°C, and in a sterile single-dose vial of 10 mL. The tranexamic acid USP 100 mg is present in every mL of the sterile aqueous solution for intravenous injection. Prescribing information should be referred to for the usual dosage. The product is distributed by AuroMedics Pharma LLC and manufactured in India.*

FDA Label Image

Vial (Vial Label Update)

This is a description of a medication called Tranexamic Acid Injection, USP, by the pharmaceutical company AuroMedics. The medication is intended for intravenous use only and comes in a 10 mL sterile single-dose vial. Each mL of the sterile aqueous solution contains tranexamic acid USP 100mg. The medication should be stored at room temperature and discarded if any portion is unused. Specific dosages should be determined and overseen by a prescribing healthcare provider.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.